Tello-Medina RI, Monsiváis-Santoyo TG, Gámez-Gómez E

Language: Spanish
References: 15
Page: 29-33
PDF size: 205.87 Kb.

ABSTRACT

The incidence of COVID-19 and its mortality worldwide continues to rise, challenging health systems and even more so in ours which is fragmented. There is no evidence of transmission of any coronavirus (SARS-CoV-2, SARS-CoV, MERS) through ocular tissue, so the risk of its transmission to both the team involved in the management of the cornea (team proctor and staff eye bank) and the recipient are precautionary, following agreed and changing international and national guidelines. The National Transplant Center, together with the members of the National Transplant Subsystem and the collegiate groups of scientific associations, professional experts and civil society organizations issued the National Plan for the Reactivation of the Donation and Transplantation programs, so acting before This new "COVIDANEITY" conditions must maintain the safety of all health personnel involved in any stage of the process.

REFERENCES

1. Centros para el Control y la Prevención de Enfermedades (EE.UU). Nuevo coronavirus 2019. Disponible en: https://www.cdc.gov/coronavirus/COVID-2019/hcp/clinical-criteria.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2FCOVID-2019%2Fclinical-criteria.html

2. Bayyoud T, Iftner A, Iftner T, Bartz-Schmidt KU, Rohrbach JM, Ueffing M et al. Absence of severe acute respiratory syndrome-coronavirus-2 rna in human corneal tissues. Cornea. 2021; 40 (3): 342-347. doi: 10.1097/ICO.0000000000002479.

3. Tello-Medina RI, Verdiguel-Sotelo K. Consideraciones para la donación y trasplante de tejido ocular en México durante la pandemia de COVID-19. Rev Mex Traspl. 2020; 9 (Suppl: 2): 216-221. doi:10.35366/94511.

4. US Food & Drug Administration, US Department of Health & Human Services. Updated information for human cell, tissue, or cellular or tissue-based product (HCT/P) establishments regarding the COVID-19 pandemic. 2 July 2020. Available in: https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/updated-information-human-cell-tissue-or-cellular-or-tissue-based-product-hctp-establishments.

5. Gupta PC, Kumar MP, Ram J. COVID-19 pandemic from an ophthalmology point of view. Indian J Med Res. 2020; 151 (5): 411-418.

6. Secretaría de Salud/Centro Nacional de Trasplantes. Plan de reactivación de los programas de donación y trasplantes [actualización 11 de agosto de 2020].

7. Aburto-Morales JS, Romero-Méndez J, Lucio-García CA, Madrigal-Bustamante JA. México ante la epidemia de COVID-19 (SARS-CoV-2) y las recomendaciones al Subsistema Nacional de Donación y Trasplante. Rev Mex Traspl. 2020; 9 (1): 6-14.

8. WHO. Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected. Geneva: WHO; 2020. Interim guidance. 25 January 2020. Available in: https://covid-19.conacyt.mx/jspui/bitstream/1000/5134/1/1108313.pdf

9. Eye Bank Association of America. Information about COVID-19 (coronavirus) is being released rapidly. we are posting updates here as we get them. These recommendations have been updated as of July 31, 2020. [Consulta 16 de agosto de 2020] Available in: https://restoresight.org/?s=coronavirus

10. Sharma N, D'Souza S, Nathawat R, Sinha R, Gokhale NS, Fogla R et al. All India Ophthalmological Society - Eye Bank Association of India consensus statement on guidelines for cornea and eyebanking during COVID-19 era. Indian J Ophthalmol. 2020; 68 (7): 1258-1262.

11. COVID-19 Update Guidance and screening Recommendations by Eye Bank Association of America date 14 Abril 2020. [Acceso 16 de agosto de 2020] Available in: http.//restoresight.org/covid-19-updates/.

12. Reglamento de la Ley General de Salud en Materia de Trasplantes. Nuevo Reglamento publicado en el Diario Oficial de la Federación el 26 de marzo de 2014. Disponible en: http://www.diputados.gob.mx/LeyesBiblio/regley/Reg_LGS_MT.pdf

13. Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect. 2020; 104 (3): 246-251.

14. Busin M, Yu AC, Ponzin D. Coping with COVID-19: an italian perspective on corneal surgery and eye banking in the time of a pandemic and beyond. Ophthalmology. 2020; 127 (9): e68-e69.

15. Gupta N, Dhasmana R, Maitreya A, Badahur H. Glycerol-preserved corneal tissue in emergency corneal transplantation: An alternative for fresh corneal tissue in COVID-19 crisis. Indian J Ophthalmol. 2020; 68 (7): 1412-1416.